Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation
Open Access
- 2 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 17 (3), 551-561
- https://doi.org/10.1038/cdd.2009.141
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Explaining Michigan: Developing an Ex Post Theory of a Quality Improvement ProgramThe Milbank Quarterly, 2011
- Features of assessment learners use to make informed self-assessments of clinical performanceMedical Education, 2011
- Combining Radiotherapy with APO010 in Cancer TreatmentClinical Cancer Research, 2009
- Improving patient safety in intensive care units in MichiganJournal of Critical Care, 2008
- To kill a tumor cell: the potential of proapoptotic receptor agonistsJCI Insight, 2008
- Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximideExperimental Cell Research, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Nitric Oxide Negatively Regulates Fas CD95-induced Apoptosis through Inhibition of Ubiquitin-Proteasome-mediated Degradation of FLICE Inhibitory ProteinOnline Journal of Public Health Informatics, 2005
- c-Jun N-terminal Kinase Contributes to Apoptotic Synergy Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand plus DNA Damage in Chemoresistant, p53 Inactive Mesothelioma CellsOnline Journal of Public Health Informatics, 2003
- The Hallmarks of CancerCell, 2000